key: cord-0252238-c9pxjmru
authors: Bozorgmehr, Rama; Tajabadi, Zohreh
title: Hemoptysis and Hematuria as the Initial Symptoms of COVID-19: a Case Report
date: 2021-01-03
journal: Tanaffos
DOI: nan
sha: debee24d135586d4b85865605fdbb0900f2286af
doc_id: 252238
cord_uid: c9pxjmru

Since SARS-CoV-2 virus emerging in winter 2019 in Wuhan, Hubei, China, COVID-19 has spread among different countries. The novel corona virus has affected more than 15,000,000 people all around the world. Becoming pandemic, COVID-19 is a major concern for both people and health systems. Novel corona virus affects multiple organs such as lungs and kidneys which can lead to acute respiratory distress syndrome and acute kidney injury (AKI) ending to death. Furthermore, patients with COVID-19 may present different atypical symptoms making the diagnoses more complicated. The current patient presented to the emergency department with a 7-day history of hemoptysis and hematuria which are among the less common symptoms among patients infected with SARS-CoV-2 virus. In addition to delayed diagnosis, atypical symptoms and signs make management and treatment more difficult. Awareness of new, atypical symptoms and the effective treatment is associated with better outcome and prognosis.

Since COVID-19 arising in late December 2019 in Wuhan, Hubei, China, many patients are infected with this novel pathogen, named as SARS-CoV-2 virus.

Nowadays, COVID-19 (first known as 2019-nCoV) has spread worldwide and affected almost 16,000,000 people in different countries. Resulting in high morbidity and mortality rate, COVID-19 pandemic is now a major concern and threat for health systems.

Although the most common symptoms of the disease are fever, cough, shortness of breath, myalgia and fatigue (1) , evidences show that patients with COVID-19 may complain of atypical symptoms such as upper respiratory tract or gastrointestinal symptoms. In addition to lungs, the novel corona virus can affect multiple organs such as heart, brain and kidneys.

Hematuria is one of the less common symptoms among patients with acute kidney injury (AKI) induced by SARS-CoV-2 virus (2). On the other hand, hemoptysis is among the rare symptoms with a prevalence of up to 5% (3, 4 Despite supportive, anti-viral and antibiotic therapy, the patient died due to respiratory failure and multiorgan damage on the third day of hospitalization. 

The authors have no conflicts of interest.

Clinical Characteristics of Coronavirus Disease

Caution on kidney dysfunctions of COVID-19 patients. The Lancet Infectious Diseases

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Is coronavirus disease 2019 (COVID-19) associated with renal involvement? A review of century infection

COVID-19 nephropathy; an emerging condition caused by novel coronavirus infection

Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist

Novel Coronavirus (COVID-19) Pneumonia with Hemoptysis as the Initial Symptom: CT and Clinical Features